Here are the latest quarterly results of Lupin. For more details, see the Lupin financial fact sheet and Lupin share price and chart. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-19* |
3
Jun-19* |
3
Sep-19* |
3
Dec-19* |
3
Mar-20* |
3
Jun-20* |
3
Sep-20* |
3
Dec-20* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 44,063 | 44,184 | 43,597 | 37,693 | 38,457 | 35,279 | 38,350 | 40,174 | |
Other income | Rs m | 865 | 722 | 1,333 | 936 | 2,086 | 433 | 250 | 212 | |
Turnover | Rs m | 44,928 | 44,906 | 44,929 | 38,629 | 40,543 | 35,711 | 38,600 | 40,385 | |
Expenses | Rs m | 35,340 | 35,582 | 36,286 | 33,402 | 33,204 | 30,398 | 32,538 | 32,386 | |
Gross profit | Rs m | 8,677 | 8,605 | 1,846 | 1,404 | 6,084 | 4,881 | 5,812 | 7,787 | |
Depreciation | Rs m | 2,808 | 3,171 | 3,215 | 2,532 | 2,143 | 2,146 | 2,127 | 2,443 | |
Interest | Rs m | 855 | 856 | 865 | 886 | 1,074 | 443 | 336 | 309 | |
Profit before tax | Rs m | 5,879 | 5,300 | -901 | -1,078 | 4,954 | 2,725 | 3,598 | 5,247 | |
Tax | Rs m | 2,998 | 2,280 | 343 | 7,670 | 1,051 | 1,643 | 1,467 | 835 | |
Profit after tax | Rs m | 2,881 | 3,021 | -1,244 | -8,748 | 3,903 | 1,081 | 2,131 | 4,412 | |
Gross profit margin | % | 19.7 | 19.5 | 4.2 | 3.7 | 15.8 | 13.8 | 15.2 | 19.4 | |
Effective tax rate | % | 51.0 | 43.0 | -38.1 | -711.4 | 21.2 | 60.3 | 40.8 | 15.9 | |
Net profit margin | % | 6.5 | 6.8 | -2.9 | -23.2 | 10.1 | 3.1 | 5.6 | 11.0 | |
Diluted EPS | Rs | 6.4 | 6.7 | -2.7 | -19.3 | 8.6 | 2.4 | 4.7 | 9.7 | |
Diluted EPS (TTM) | Rs | 13.4 | 15.6 | 6.9 | -9.0 | -6.8 | -11.1 | -3.6 | 25.5 | |
![]() |
Read: Lupin 2QFY21 Result Performance Review
More Pharmaceuticals Company Quarterly Results: NOVARTIS J.B.CHEMICALS DR. REDDYS LAB PROCTER & GAMBLE HEALTH IPCA LABS
Compare LUPIN With: NOVARTIS J.B.CHEMICALS DR. REDDYS LAB PROCTER & GAMBLE HEALTH IPCA LABS
Compare LUPIN With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)
The week belonged to the bulls after bears ended the party in February. March started with gains for the bulls but historically, March has been a bears' month.
Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.
For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.
For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.
Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.
More Views on NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll show you how to get started on the path to daily trading profits.
An Indian company founded three decades ago in a garage caught my attention...
In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.
More